Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Infleqtion, Inc. (INFQ)
NYSEInformation TechnologyComputer HardwareSnapshot 2026-11-04
$8.56+1.42%
Close 2026-11-04 · 1-day change
NYSEInformation TechnologyComputer HardwareSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Oct 4, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for INFQ yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Scale logical qubits to 100 by 2028 | The company aims to scale logical qubits to 100 by 2028. | Intact | fails to achieve 100 logical qubits by 2028 | Qualitative condition This condition has no defined numerical measure. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in a supplied disclosure. Management reported: “Document Exhibit 99.1 Infleqtion Achieves 30 Entangled Logical Qubits on Its Sqale Quantum Computer Sqale reaches key 2026 roadmap milestone as Infleqtion builds toward 100 logical qubits and develops quantum applications with customers LOUISVILLE, Colo.--(BUSINESS WIRE)--September 24, 2026-- Infleqtion (NYSE: INFQ), a global leader in quantum computing and quantum sensing powered by neutral-atom technology, today announced it has achieved 30 entangled logical qubits using just 80 physical qubits on its Sqale™ quantum computing platform, delivering a key milestone on its 2026 roadmap.” |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 16, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is speculative growth: the business is pursuing quantum-computing development while still reporting operating losses. The thesis is in a watch state, with low overall confidence and high risk.
The evidence does not provide a valuation level or clear account of what market expectations already assume, so whether the shares are cheap, fair, or expensive versus peers cannot be assessed. The priced-in snapshot reports low fragility, but that does not establish valuation.
Near term, recent results show revenue and gross profit growth and a narrower operating loss from the first to the second quarter of 2026, though the business remains loss-making. Management says the 100-logical-qubit goal for 2028 is on track after reaching 30, while customer application work remains at an early, mixed stage; the risk label has risen to high.
Over the multi-year view, the thesis hinges on whether INFQ can meet its quantum-computing roadmap and turn customer collaborations into useful applications. Near-term conditions also matter: rate cuts or steadier results from large technology peers could support the sector, while GDP growth falling below 2% could weigh on it.
For the next 1 to 3 years, INFQ remains an early-stage, high-risk business with some operating progress but limited evidence of durable commercial results. The thesis depends on roadmap delivery, customer applications, and improving financial performance. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Maintain positive operating cash flow | Operating cash flow has turned positive, indicating better financial management. | Intact | operating cash flow turns negative again | Cash from operations: $13.185M FY2026-Q2; GAAP. Published target: >=0.0M. Target period is not explicitly aligned with this observation. Aug 18, 202613,185,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Achieve revenue growth from $13.54M in Q2 2026 | A primary condition in Infleqtion, Inc.'s published investment case. The stated target is >=15% YoY growth. | Intact | revenue growth falls below 15% YoY | Required source inputs unavailable Cannot calculate Revenue growth from the available matching source inputs. Missing inputs are not treated as zero. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Oct 4, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$-0.24 → $-0.24 · observed estimates
$0.06B → $0.06B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-08-27 | $-0.24 | $56,400,090 | 1 / 2 |
| 2026-08-28 | $-0.24 | $56,400,090 | 1 / 2 |
| 2026-08-29 | $-0.24 | $56,399,490 | 1 / 2 |
| 2026-08-30 | $-0.24 | $56,399,490 | 1 / 2 |
| 2026-08-31 | $-0.24 | $56,399,490 | 1 / 2 |
| 2026-09-01 | $-0.24 | $56,399,490 | 1 / 2 |
| 2026-09-02 | $-0.24 | $56,399,490 | 1 / 2 |
| 2026-09-03 | $-0.24 | $56,399,490 | 1 / 2 |
| 2026-09-04 | $-0.24 | $56,399,490 | 1 / 2 |
| 2026-09-05 | $-0.24 | $56,199,908 | 2 / 2 |
| 2026-09-06 | $-0.24 | $56,199,908 | 2 / 2 |
| 2026-09-07 | $-0.24 | $56,199,908 | 2 / 2 |
| 2026-09-08 | $-0.24 | $56,199,908 | 2 / 2 |
| 2026-09-09 | $-0.24 | $56,199,908 | 2 / 2 |
| 2026-09-10 | $-0.24 | $56,199,908 | 2 / 3 |
| 2026-09-11 | $-0.24 | $56,199,908 | 2 / 3 |
| 2026-09-12 | $-0.24 | $56,199,908 | 2 / 3 |
| 2026-09-13 | $-0.24 | $56,199,908 | 2 / 3 |
| 2026-09-14 | $-0.24 | $56,199,908 | 2 / 3 |
| 2026-09-15 | $-0.24 | $56,199,908 | 2 / 3 |
| 2026-09-16 | $-0.24 | $56,199,908 | 2 / 3 |
| 2026-09-17 | $-0.24 | $56,199,908 | 2 / 3 |
| 2026-09-18 | $-0.24 | $56,199,908 | 2 / 3 |
| 2026-09-19 | $-0.24 | $56,199,908 | 2 / 3 |
| 2026-09-20 | $-0.24 | $56,199,908 | 2 / 3 |
| 2026-09-21 | $-0.24 | $56,199,908 | 2 / 3 |
| 2026-09-22 | $-0.24 | $56,199,575 | 2 / 3 |
| 2026-09-23 | $-0.24 | $56,199,575 | 2 / 3 |
| 2026-09-24 | $-0.24 | $56,199,575 | 2 / 3 |
| 2026-09-25 | $-0.24 | $56,199,575 | 2 / 3 |
| 2026-09-26 | $-0.24 | $56,199,575 | 2 / 3 |
| 2026-09-27 | $-0.24 | $56,199,575 | 2 / 3 |
| 2026-09-28 | $-0.24 | $56,199,575 | 2 / 3 |
| 2026-09-29 | $-0.24 | $56,199,575 | 2 / 3 |
| 2026-09-30 | $-0.24 | $56,199,575 | 2 / 3 |
| 2026-10-01 | $-0.24 | $56,199,575 | 2 / 3 |
| 2026-10-02 | $-0.24 | $56,199,575 | 2 / 3 |
| 2026-10-03 | $-0.24 | $56,199,575 | 2 / 3 |
| 2026-10-04 | $-0.23 | $56,199,575 | 2 / 3 |
| 2026-10-05 | $-0.23 | $56,199,575 | 2 / 3 |
| 2026-10-06 | $-0.23 | $56,199,575 | 2 / 3 |
| 2026-10-07 | $-0.23 | $56,199,575 | 2 / 3 |
| 2026-10-08 | $-0.23 | $56,199,575 | 2 / 3 |
| 2026-10-09 | $-0.23 | $56,199,575 | 2 / 3 |
| 2026-10-10 | $-0.23 | $56,199,575 | 2 / 3 |
| 2026-10-11 | $-0.23 | $56,199,575 | 2 / 3 |
| 2026-10-12 | $-0.23 | $56,199,575 | 2 / 3 |
| 2026-10-13 | $-0.23 | $56,199,575 | 2 / 3 |
| 2026-10-14 | $-0.23 | $56,199,575 | 2 / 3 |
| 2026-10-15 | $-0.23 | $56,200,108 | 2 / 3 |
| 2026-10-16 | $-0.23 | $56,200,108 | 2 / 3 |
| 2026-10-17 | $-0.23 | $56,200,108 | 2 / 3 |
| 2026-10-18 | $-0.24 | $55,903,664 | 2 / 3 |
| 2026-10-19 | $-0.24 | $55,903,664 | 3 / 3 |
| 2026-10-20 | $-0.24 | $55,903,664 | 3 / 3 |
| 2026-10-21 | $-0.24 | $55,903,664 | 3 / 3 |
| 2026-10-22 | $-0.24 | $55,903,664 | 3 / 3 |
| 2026-10-23 | $-0.24 | $55,903,664 | 3 / 3 |
| 2026-10-24 | $-0.24 | $55,903,664 | 3 / 3 |
| 2026-10-25 | $-0.24 | $55,903,664 | 3 / 3 |
| 2026-10-26 | $-0.24 | $55,903,664 | 3 / 3 |
| 2026-10-27 | $-0.24 | $55,903,664 | 3 / 3 |
| 2026-10-28 | $-0.24 | $55,903,664 | 3 / 3 |
| 2026-10-29 | $-0.24 | $55,903,664 | 3 / 3 |
| 2026-10-30 | $-0.24 | $55,903,664 | 3 / 3 |
| 2026-10-31 | $-0.24 | $55,903,664 | 3 / 3 |
| 2026-11-01 | $-0.24 | $55,903,664 | 3 / 3 |
| 2026-11-02 | $-0.24 | $55,903,664 | 3 / 3 |
| 2026-11-03 | $-0.24 | $55,903,664 | 3 / 3 |
| 2026-11-04 | $-0.24 | $55,903,664 | 3 / 3 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 6 Buy / Strong Buy · 1 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 1 recorded
0 raises · 0 cuts · 0 unchanged · 1 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.